Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.78 SEK | +0.11% | -5.62% | -55.61% |
Mar. 01 | Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows | MT |
Mar. 01 | Sector Update: Health Care Stocks Edge Higher Premarket Friday | MT |
Sales 2023 | 16.84M 1.55M | Sales 2024 * | 62M 5.71M | Capitalization | 198M 18.23M |
---|---|---|---|---|---|
Net income 2023 | -95M -8.75M | Net income 2024 * | -37M -3.41M | EV / Sales 2023 | 15.3 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3.19 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 23 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.76% |
1 day | +0.11% | ||
1 week | -5.62% | ||
Current month | -7.68% | ||
1 month | -4.91% | ||
3 months | -14.83% | ||
6 months | -65.44% | ||
Current year | -55.61% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 10-12-31 | |
Thomas Feldthus
CEO | Chief Executive Officer | 64 | 10-12-31 |
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Director/Board Member | 66 | 14-12-31 | |
Anna Ljung
BRD | Director/Board Member | 44 | 18-01-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.78 | +0.11% | 17 211 |
24-04-24 | 1.778 | +0.11% | 202,982 |
24-04-23 | 1.776 | -1.33% | 158,143 |
24-04-22 | 1.8 | -2.70% | 242,598 |
24-04-19 | 1.85 | -1.91% | 320,759 |
Delayed Quote Nasdaq Stockholm, April 25, 2024 at 03:33 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.61% | 18.16M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.11% | 22.2B | |
-16.53% | 21.23B | |
-8.89% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- SANION Stock